Legal Representation
Attorney
Nicole K. McLaughlin, Esquire
USPTO Deadlines
Next Deadline
507 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2006-11-28)
Due Date
November 28, 2026
Grace Period Ends
May 28, 2027
Application History
26 events| Date | Code | Type | Description |
|---|---|---|---|
| May 3, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| May 3, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| May 3, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| May 3, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| May 3, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Jan 3, 2017 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Jan 3, 2017 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| Jan 3, 2017 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| Jan 3, 2017 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| Oct 21, 2016 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
| Nov 28, 2015 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| Dec 17, 2012 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Dec 17, 2012 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Dec 17, 2012 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Nov 19, 2012 | E815 | I | TEAS SECTION 8 & 15 RECEIVED |
| Apr 6, 2011 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Apr 6, 2011 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jan 30, 2008 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Nov 28, 2006 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Sep 12, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Aug 23, 2006 | NPUB | O | NOTICE OF PUBLICATION |
| Jul 20, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Jul 10, 2006 | ALIE | A | ASSIGNED TO LIE |
| Jun 30, 2006 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 29, 2006 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 24, 2006 | NWAP | I | NEW APPLICATION ENTERED IN TRAM |
Detailed Classifications
Class 042
clinical research and development of treatments for pervasive developmental disorders, dysautonomia, and neurological disorders
First Use Anywhere:
Jan 1, 2004
First Use in Commerce:
Jan 1, 2004
Additional Information
Pseudo Mark
CURE MARK
Classification
International Classes
042